1
|
Tanaka H, Urabe Y, Takemoto H, Ishibashi K, Konishi H, Matsubara Y, Takehara Y, Morimoto S, Tanino F, Yamamoto N, Teshima H, Mizuno J, Hirata I, Tamari H, Tsuboi A, Yamashita K, Kotachi T, Takigawa H, Yuge R, Oka S. Can underwater endoscopic mucosal resection be an alternative to conventional endoscopic mucosal resection for superficial non-ampullary duodenal epithelial tumors? DEN Open 2024; 4:e312. [PMID: 37927952 PMCID: PMC10624252 DOI: 10.1002/deo2.312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/16/2023] [Revised: 10/16/2023] [Accepted: 10/21/2023] [Indexed: 11/07/2023]
Abstract
Objectives Underwater endoscopic mucosal resection (UEMR) is a simpler procedure for superficial non-ampullary duodenal epithelial tumors (SNADET) than conventional endoscopic mucosal resection (cEMR). This study aimed to evaluate whether cEMR can be substituted by UEMR for SNADET in terms of effectiveness, safety, and learning curve. Methods A total of 157 consecutive patients with 203 SNADETs ≤20 mm in diameter, including 107 lesions resected by cEMR and 96 lesions resected by UEMR, between January 2019 and May 2023, were retrospectively recruited. The treatment outcomes were compared between the cEMR and UEMR groups. The risk factors for incomplete resection by UEMR were analyzed using univariate and multivariate analyses. Lesions in the UEMR group were divided chronologically into five periods; thereafter, the en bloc resection rate and procedure time were compared. Results No significant differences existed between the cEMR and UEMR groups in the mean procedure time (3.9 min vs. 3.6 min, p = 0.1380) or en bloc resection rate (91% vs. 94%, p = 0.4138). No perforation was observed in either group. Tumor size was an independent risk factor for incomplete resection using UEMR (p < 0.01). The history of biopsy was not associated with incomplete resection using UEMR. The en bloc resection rate of UEMR was 100% (20/20) in the first period and ranged from 90% to 100% over all periods. Conclusion UEMR is safe and effective for SNADET ≤20 mm, regardless of a history of biopsy, and is easy to learn. Thus, UEMR can serve as an alternative to cEMR.
Collapse
Affiliation(s)
- Hidenori Tanaka
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Yuji Urabe
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Hiroki Takemoto
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Kazuki Ishibashi
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Hirona Konishi
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Yuka Matsubara
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Yudai Takehara
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Shin Morimoto
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Fumiaki Tanino
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Noriko Yamamoto
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Hajime Teshima
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Junichi Mizuno
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Issei Hirata
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Hirosato Tamari
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Akiyoshi Tsuboi
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Ken Yamashita
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Takahiro Kotachi
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Hidehiko Takigawa
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Ryo Yuge
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| | - Shiro Oka
- Department of GastroenterologyHiroshima University HospitalHiroshimaJapan
| |
Collapse
|
2
|
Takemoto H, Kotachi T, Teshima H, Tamari H, Tsuboi A, Tanaka H, Yamashita K, Urabe Y, Ishikawa A, Oka S. Verrucous gastritis-like lesion in intramucosal Helicobacter pylori-uninfected signet ring cell carcinoma with poorly differentiated adenocarcinoma. Clin J Gastroenterol 2024:10.1007/s12328-024-01952-9. [PMID: 38520641 DOI: 10.1007/s12328-024-01952-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Accepted: 03/10/2024] [Indexed: 03/25/2024]
Abstract
In Japan, accessible Helicobacter pylori (Hp) eradication therapy is associated with an increase in the prevalence of gastric cancers (GCs) in Hp uninfected stomachs. Signet ring cell carcinoma (SRCC) is the most common of these GCs. Intramucosal SRCC with poorly differentiated adenocarcinoma (PDA) occurring in Hp uninfected gastric mucosa is rare; furthermore, many Hp uninfected pure SRCCs exhibit discoloration and flat or slightly depressed lesions, and morphological elevation is relatively rare. We report a case of intramucosal SRCC with PDA with an elevated, verrucous gastritis-like lesion in a 57-year-old male patient. In the present case, the PDA area showed dense tumor cell growth and coexisting desmoplastic and fibrotic reactions. Histopathology and immunohistochemical staining identified extensive fibromuscular obliteration with smooth muscle bundles extending from the muscularis mucosa into the lamina propria. The patient underwent curative endoscopic submucosal dissection. The reporting and analysis of such rare cases may lead to a better understanding of the characteristics of advanced Hp uninfected GCs.
Collapse
Affiliation(s)
- Hiroki Takemoto
- Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8553, Japan
| | - Takahiro Kotachi
- Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8553, Japan.
| | - Hajime Teshima
- Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8553, Japan
| | - Hirosato Tamari
- Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8553, Japan
| | - Akiyoshi Tsuboi
- Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8553, Japan
| | - Hidenori Tanaka
- Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8553, Japan
| | - Ken Yamashita
- Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8553, Japan
| | - Yuji Urabe
- Department of Gastrointestinal Endoscopy and Medicine, Hiroshima University Hospital, Hiroshima, Japan
| | - Akira Ishikawa
- Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
| | - Shiro Oka
- Department of Gastroenterology, Hiroshima University Hospital, 1-2-3 Kasumi, Minamiku, Hiroshima, 734-8553, Japan
| |
Collapse
|
3
|
Asano T, Takemoto H, Horita T, Tokutake T, Izuo N, Mochizuki T, Nitta A. Sleep disturbance after cessation of cannabis administration in mice. Neuropsychopharmacol Rep 2023; 43:505-512. [PMID: 36905178 PMCID: PMC10739061 DOI: 10.1002/npr2.12329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2022] [Revised: 02/23/2023] [Accepted: 02/24/2023] [Indexed: 03/12/2023] Open
Abstract
Cannabis withdrawal syndrome (CWS) in humans is characterized by various somatic symptoms, including sleep disturbances. In the present study, we investigated sleep alterations in mice after the cessation of arachidonylcyclopropylamide (ACPA), a cannabinoid type 1 receptor agonist, administration. ACPA-administered mice (ACPA mice) displayed an increased number of rearings after the cessation of ACPA administration compared to saline-administered mice (Saline mice). Moreover, the number of rubbings was also decreased in ACPA mice compared with those of the control mice. Electroencephalography (EEG) and electromyography (EMG) were measured for 3 days after the cessation of ACPA administration. During ACPA administration, there was no difference in the relative amounts of total sleep and wake time between ACPA and Saline mice. However, ACPA-induced withdrawal decreased total sleep time during the light period in ACPA mice after ACPA cessation. These results suggest that ACPA cessation induces sleep disturbances in the mouse model of CWS.
Collapse
Affiliation(s)
- Takashi Asano
- Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical SciencesGraduate School of Medicine and Pharmaceutical Sciences, University of ToyamaToyamaJapan
| | - Hiroki Takemoto
- Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical SciencesGraduate School of Medicine and Pharmaceutical Sciences, University of ToyamaToyamaJapan
| | - Tomoya Horita
- Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical SciencesGraduate School of Medicine and Pharmaceutical Sciences, University of ToyamaToyamaJapan
| | - Tomohiro Tokutake
- Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical SciencesGraduate School of Medicine and Pharmaceutical Sciences, University of ToyamaToyamaJapan
| | - Naotaka Izuo
- Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical SciencesGraduate School of Medicine and Pharmaceutical Sciences, University of ToyamaToyamaJapan
| | - Takatoshi Mochizuki
- Department of BiologyGraduate School of Science & Engineering, University of ToyamaToyamaJapan
| | - Atsumi Nitta
- Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical SciencesGraduate School of Medicine and Pharmaceutical Sciences, University of ToyamaToyamaJapan
| |
Collapse
|
4
|
Takemoto H, Kado A, Kitani H, Katsuura C, Mizuno S, Saito H, Makari Y. Examination Of The Influence Of Polypharmacy On Nutritional Management Of Inpatients From The Results Of The Survey On Nutritionday. Clin Nutr ESPEN 2023. [DOI: 10.1016/j.clnesp.2022.09.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/28/2023]
|
5
|
Asayama N, Nagata S, Yukutake M, Takemoto H, Shigita K, Aoyama T, Fukumoto A, Mukai S. A Rare Case of Delayed Perigastric Abscess after Curative Resection of Early Gastric Cancer by Uncomplicated Endoscopic Submucosal Dissection: Successful Treatment with Endoscopic Ultrasound-guided Drainage. Intern Med 2021; 60:1383-1387. [PMID: 33281159 PMCID: PMC8170251 DOI: 10.2169/internalmedicine.5990-20] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
A 72-year-old man had undergone uncomplicated endoscopic submucosal dissection (ESD) with en bloc resection of a localized 20-mm IIc lesion in the anterior wall of the gastric angle. Twenty-eight days later, he was re-admitted with epigastric pain of one-week duration. Contrast-enhanced computed tomography (CT) revealed a 60-mm mass bordered by viscera; repeat endoscopy confirmed a smooth elevated submucosal tumor at the greater curvature on the oral side of the post-ESD ulcer. We diagnosed him with a perigastric abscess as a complication of ESD and performed endoscopic ultrasound-guided drainage. Subsequently, the symptoms and blood inflammatory parameters improved, and follow-up CT showed the disappearance of the abscess.
Collapse
Affiliation(s)
- Naoki Asayama
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Japan
| | - Shinji Nagata
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Japan
| | - Masanobu Yukutake
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Japan
| | - Hiroki Takemoto
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Japan
| | - Kenjiro Shigita
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Japan
| | - Taiki Aoyama
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Japan
| | - Akira Fukumoto
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Japan
| | - Shinichi Mukai
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Japan
| |
Collapse
|
6
|
Aoyama T, Takemoto H, Takeuchi Y, Shigita K, Asayama N, Fukumoto A, Mukai S, Nagata S. Step-clipping method can improve the detectability of the target lesion in colonic diverticular bleeding. Endosc Int Open 2021; 9:E356-E362. [PMID: 33655034 PMCID: PMC7895651 DOI: 10.1055/a-1322-2259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/02/2020] [Accepted: 10/22/2020] [Indexed: 11/03/2022] Open
Abstract
Background and study aims Despite the information regarding extravasation from contrast-enhanced computed tomography (CECT), the detectability of the target diverticulum by colonoscopy remains unsatisfactory in colonic diverticular bleeding (CDB). The lack of common signs recognizable on CT and endoscopic images makes it difficult to set a region of interest; however, this can be overcome with the "step-clipping" method, a strategic marking technique for revealing the target. We aimed to investigate the clinical performance of the step-clipping method in patients with CDB. Patients and methods Eighty-seven patients diagnosed with CDB with extravasation using CECT who underwent colonoscopy between August 2007 and February 2020 were included. Patients were divided into two categories: the traditional group (those who underwent colonoscopy from August 2007 to May 2017, n = 54) and the step-clipping group (those who underwent colonoscopy from June 2017 to February 2020, n = 33). Results The detection rate for the responsible diverticulum was significantly higher in the step-clipping group than in the traditional group (94 % vs 63 %; P = .0013). The step-clipping group had a shorter average search time during colonoscopy (9.6 vs 40.5 minutes; P < .0001) and lower re-bleeding rate after the initial colonoscopy (6 % vs 26 %; P = .02) than the traditional group, which facilitated earlier hospital discharge (5.4 vs 6.8 days; P = .027). Conclusions Colonoscopy using the step-clipping method can improve the detectability of the target lesion within a shorter time, thus leading to lower re-bleeding rates and earlier hospital discharge.
Collapse
Affiliation(s)
- Taiki Aoyama
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
| | - Hiroki Takemoto
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
| | - Yukari Takeuchi
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
| | - Kenjiro Shigita
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
| | - Naoki Asayama
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
| | - Akira Fukumoto
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
| | - Shinichi Mukai
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
| | - Shinji Nagata
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
| |
Collapse
|
7
|
Takemoto H, Kado A, Kitani H, Katsuura C, Mizuno S, Saito H, Takachi K. A study on the current state of nutrition therapy for end-stage cancer patients based on the results of nutritionday. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
8
|
Takemoto H, Aoyama T, Nagata S. Clinical efficacy of partial endoscopic band ligation for treatment of large-orifice colonic diverticular bleeding. VideoGIE 2020; 5:32-33. [PMID: 31922080 PMCID: PMC6945227 DOI: 10.1016/j.vgie.2019.09.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
9
|
Nakano T, Suenari K, Suruga K, Takemoto H, Hashimoto Y, Tomomori S, Higaki T, Ooi K, Dai K, Nakama Y, Kawase T, Nishioka K, Otsuka M, Masaoka Y, Shiode N. P4760New minimally invasive and tailor-made strategy for cryoballoon ablation in patients with paroxysmal atrial fibrillation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1136] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Currently, cryoballoon ablation (CBA) has proven to be highly effective in achieving free from atrial fibrillation (AF), especially paroxysmal AF. However, the optimal freezing protocol for each patient to achieve successful pulmonary vein isolation by only CBA is still uncertain. The aim of this study was to evaluate the clinical implications of a reduction in the freezing duration (<180s) during CBA guided by the time to target temperature.
Methods
From November 2015 to August 2018, 286 consecutive paroxysmal AF patients undergoing CBA were enrolled. We compared 107 patients undergoing a tailor-made CBA procedure (Group A; August 2017-August 2018) to 179 patients with a standard CBA procedure (Group B; November 2015–July 2017). In Group A, the freezing duration was reduced to 150s when the temperature reached ≤−40°C within 40s. Furthermore, we reduced it to 120s when it reached ≤−50°C within 60s. In the other patients, the freezing time was 180s except for excessive freezing over −60°C and/or emergent situations while monitoring the esophageal temperature and for phrenic nerve injury as in Group B.
Results
The baseline clinical characteristics were similar between two groups. In Group A, 89 patients (83%) underwent CBA with a reduction in the freezing time. The rate of having reduction time in left inferior PV (LIPV) and right inferior PV (RIPV) was lower compared with left superior PV (LSPV) and right superior PV (RSPV) (respectively 17%, 29%, 56%, and 63.5%). However, for right inferior PV, in 31 patients having the reduced freezing time, none of them required touch-up ablation. Although the procedure time and frequency of touch-up ablation did not differ between the 2 groups, total freezing time for each PV was significantly shorter in Group A than Group B as shown in figure (LSPV: 164±28s vs. 216±67s; p<0.001, LIPV: 187±44s vs. 218±69s; p<0.001, RSPV: 147±31s vs. 192±51s; p<0.001, RIPV: 180±50 vs. 218±73s; p<0.001). The AF free survival rate during the follow-up period (356±167 days) was similar between the 2 groups (log-rank test, p=0.38). Furthermore, the complication rate was similar 2 groups.
The freezing time for each PV
Conclusion
The safety and efficacy of the new tailor-made CBA strategy were non-inferior to the standard procedure. This study showed that the unnecessary freezing time could be reduced in most of paroxysmal AF patients.
Collapse
Affiliation(s)
- T Nakano
- Hiroshima City Hospital, Hiroshima, Japan
| | - K Suenari
- Hiroshima City Hospital, Hiroshima, Japan
| | - K Suruga
- Hiroshima City Hospital, Hiroshima, Japan
| | - H Takemoto
- Hiroshima City Hospital, Hiroshima, Japan
| | | | - S Tomomori
- Hiroshima City Hospital, Hiroshima, Japan
| | - T Higaki
- Hiroshima City Hospital, Hiroshima, Japan
| | - K Ooi
- Hiroshima City Hospital, Hiroshima, Japan
| | - K Dai
- Hiroshima City Hospital, Hiroshima, Japan
| | - Y Nakama
- Hiroshima City Hospital, Hiroshima, Japan
| | - T Kawase
- Hiroshima City Hospital, Hiroshima, Japan
| | - K Nishioka
- Hiroshima City Hospital, Hiroshima, Japan
| | - M Otsuka
- Hiroshima City Hospital, Hiroshima, Japan
| | - Y Masaoka
- Hiroshima City Hospital, Hiroshima, Japan
| | - N Shiode
- Hiroshima City Hospital, Hiroshima, Japan
| |
Collapse
|
10
|
Higaki T, Nishioka K, Suruga K, Takemoto H, Nakano T, Hashimoto Y, Tomomori S, Oi K, Dai K, Kawase T, Nakama Y, Suenari K, Otsuka M, Masaoka Y, Shiode N. P2694Early and late restenosis after excimer laser coronary angioplasty and paclitaxel-coated balloon combination therapy for drug-eluting stent restenosis. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.1011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Drug-eluting stent restenosis (DES-ISR) is associated with poorer outcomes than those of bare-metal stent restenosis after treatment with paclitaxel-coated balloon (PCB), and late restenosis after PCB angioplasty for DES-ISR is a residual problem. Excimer laser coronary angioplasty (ELCA) is thought to be advantageous for ISR treatment by removing neointima. However, whether the combination of ELCA and PCB angioplasty is more effective than the use of PCB only angioplasty in DES-ISR has not been studied so far.
Purpose
We evaluated the efficacy of ELCA and PCB combination therapy for DES-ISR at mid-and late-term after revascularization.
Methods
From January 2014 to March 2016, 166 DES-ISR lesions were treated with ELCA and no-ELCA prior to PCB. Two serial angiographic follow-ups were planned for the patients (at 6–12 and 18–24 months after procedure). Acute procedural and follow-up angiographic results were assessed by quantitative coronary angiography. ELCA and no-ELCA group included 74 lesions and 92 lesions, respectively.
Results
There was no significant difference between the two groups in the clinical characteristics except the prevalence of hemodialysis, the rate of first-generation DES (37.9% vs 36.8%, p=0.897), previous stent size (2.90±0.39 mm vs 2.77±0.39 mm, p=0.063), and reference vessel diameter (2.65±0.46 mm vs 2.60±0.65 mm, p=0.593). Early follow-up angiography was performed in 66 lesions (89.1%) of ELCA group, and was done in 76 lesions (82.6%) of no-ELCA group. In the ELCA group, percentage diameter stenosis (%DS) just after procedure and at 6–12 months later were significantly smaller than those of no-ELCA group. Besides, target lesion revascularization (TLR) rate at 6–12 months after procedure was tended to be lower in the ELCA group. Late follow-up angiography was performed for 93 lesions (81.6%) of the remaining 114 lesions (excluding TLR lesion), late restenosis was found 9 lesions (18.6%) in the ELCA group and 11 lesions (24.4%) in the no-ELCA group (p=0.504). Late luminal loss was similar in both groups (0.37±0.71 mm vs 0.24±0.82 mm, p=0.438), and %DS at 12–18 months after revascularization was not different between the two groups.
Changes of %DS and TLR rate
Conclusions
%DS in the ELCA group was smaller at just after procedure and the advantage was kept even after 1-year. However, late restenosis and TLR at 2-year after revascularization for DES-ISR could not be reduced by ELCA and PCB combination therapy.
Collapse
Affiliation(s)
- T Higaki
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - K Nishioka
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - K Suruga
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - H Takemoto
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - T Nakano
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - Y Hashimoto
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - S Tomomori
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - K Oi
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - K Dai
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - T Kawase
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - Y Nakama
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - K Suenari
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - M Otsuka
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - Y Masaoka
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - N Shiode
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| |
Collapse
|
11
|
Takemoto H, Asayama N, Takeuchi Y, Ogawa Y, Tamari H, Shigita K, Aoyama T, Fukumoto A, Mukai S, Nagata S. [A case of ruptured posterior superior pancreaticoduodenal artery aneurysm successfully treated by emergency transcatheter embolization]. Nihon Shokakibyo Gakkai Zasshi 2019; 116:344-352. [PMID: 30971672 DOI: 10.11405/nisshoshi.116.344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
A man in his 40s with no remarkable past medical history was referred to our hospital with acute exacerbation of nonspecific epigastric pain by another hospital on the morning of the day of presentation. Though vital signs were stable, tenderness and guarding were observed over the entire abdomen. Contrast-enhanced computed tomography (CT) revealed a giant retroperitoneal hematoma due to a ruptured aneurysm close to the superior mesenteric artery. Emergency angiography of the superior mesenteric artery detected a ruptured 2-mm pseudoaneurysm of the posterior superior pancreaticoduodenal artery, for which embolization was immediately performed. The postoperative course was good, with the patient complaining only of transient abdominal pain due to exclusion of the hematoma on hospital day 6. His clinical symptoms disappeared with conservative treatment, and the patient was discharged on hospital day 18. Complete occlusion of the aneurysm and reduction of the hematoma was confirmed on follow-up CT. Pancreaticoduodenal artery aneurysm is an uncommon visceral artery aneurysm, and ruptured aneurysms typically result in fatal hemorrhage and high mortality. We herein report a case of ruptured aneurysm of the posterior pancreaticoduodenal artery where emergency transcatheter arterial embolization was able to save the patient's life. We also review 116 cases of pancreaticoduodenal artery aneurysm reported in Japanese literature.
Collapse
Affiliation(s)
- Hiroki Takemoto
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital
| | - Naoki Asayama
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital
| | - Yukari Takeuchi
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital
| | - Yutaro Ogawa
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital
| | - Hirosato Tamari
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital
| | - Kenjiro Shigita
- Department of Endoscopy, Hiroshima City Asa Citizens Hospital
| | - Taiki Aoyama
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital
| | - Akira Fukumoto
- Department of Endoscopy, Hiroshima City Asa Citizens Hospital
| | - Shinichi Mukai
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital
| | - Shinji Nagata
- Department of Gastroenterology, Hiroshima City Asa Citizens Hospital
| |
Collapse
|
12
|
Honda M, Matsuda C, Tanaka C, Kondo K, Takahashi T, Kosugi C, Tokunaga Y, Takemoto H, Kim H, Sakamoto J, Oba K, Mishima H. A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy for colorectal cancer: The AIRS study. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy281.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
13
|
Takemoto H, Kado A, Furukawa M, Honda Y, Kitani H, Shakushiro S, Katsuura C, Mizuno S, Saito H, Takachi K. Examination of nutritional status and prognostic prediction of terminal cancer patients based on the results of nutrition day. Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.1336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Suruga K, Dai K, Kobayashi Y, Ikegami Y, Nakao Y, Takemoto H, Higaki T, Ooi K, Kawase T, Nakama Y, Suenari K, Nishioka K, Otsuka M, Masaoka Y, Shiode N. P2275Are cholesterol crystals findings predictors for progression of non-culprit coronary plaque after acute myocardial infarction? (From optical coherence tomography study). Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p2275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- K Suruga
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - K Dai
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - Y Kobayashi
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - Y Ikegami
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - Y Nakao
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - H Takemoto
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - T Higaki
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - K Ooi
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - T Kawase
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - Y Nakama
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - K Suenari
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - K Nishioka
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - M Otsuka
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - Y Masaoka
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| | - N Shiode
- Hiroshima City Hospital, Cardiology, Hiroshima, Japan
| |
Collapse
|
15
|
Takemoto H, Fukushima R, Ishii S, Endo R, Koyama Y, Saito K, Noda S, Mihara C, Yamaguchi M, Kotani J. SUN-P229: Nutritional Status of Cancer Patients Seen from Nutritionday Oncology in Japan 2015. Clin Nutr 2017. [DOI: 10.1016/s0261-5614(17)30399-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
16
|
Fukuda K, Takemoto H, Ikeda A. Analytical approach to the temporal changes in NIRS signals to separate hemodynamic change from brain activity. Annu Int Conf IEEE Eng Med Biol Soc 2016; 2016:1393-1396. [PMID: 28268586 DOI: 10.1109/embc.2016.7590968] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
In brain function measurements by near-infrared spectroscopy (NIRS), we focus on the temporal changes in the oxygenated and deoxygenated hemoglobin concentrations and propose an analytical approach to the temporal changes of the hemoglobin concentrations' cross-correlation coefficient in the brain functional signals. The cross-correlation coefficient between the oxygenated and deoxygenated hemoglobin concentrations shows negative values for brain activity and positive values for hemodynamic changes. Experiments with a 16-channel functional NIRS system show that our proposed approach clarifies the interpretation of the measured NIRS signals and it can be used to estimate the influence of hemodynamic change on brain activity.
Collapse
|
17
|
Urata Y, Abe S, Devers B, Nakamura Y, Takemoto H, Furukawa KI. THU0072 A Novel Dose Reduction Therapy Using Biological Disease-Modifying Anti-Rheumatic Drugs To Target Matrix Metalloproteinase 3 Normalization Together with A Simplified Disease Activity Index ≤3.3 Yields Effects Non-Inferior To Standard Care in Rheumatoid Arthritis with Regards Maintaining Remission. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
18
|
Iwamoto S, Hazama S, Kin H, Takemoto H, Kobayashi K, Takahashi Y, Kobayashi M, Maeda H, Nagata N, Oba K, Sakamoto J, Mishima H. P-157 A phase II study of XELOX and Cetuximab (Erbitux) as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (FLEET2). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw199.151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
19
|
Nishimura J, Satoh T, Fukunaga M, Takemoto H, Nakata K, Ide Y, Fukuzaki T, Kudo T, Miyake Y, Yasui M, Morita S, Sakai D, Uemura M, Hata T, Takemasa I, Mizushima T, Ohno Y, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. O-001 A phase III trial of aprepitant in colorectal cancer patients receiving oxaliplatin-based chemotherapy (SENRI Trial). Ann Oncol 2015. [DOI: 10.1093/annonc/mdv235.01] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
20
|
Okada K, Takemoto H, Yamakami T, Kawata S, Imagita H. Changes in skeletal muscle tension in a rat 6-hydroxydopamin-induced Parkinson's disease model. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.2032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
21
|
Jain A, Takemoto H, Silver MD, Nagesh SVS, Ionita CN, Bednarek DR, Rudin S. Region-of-interest cone beam computed tomography (ROI CBCT) with a high resolution CMOS detector. Proc SPIE Int Soc Opt Eng 2015; 9412. [PMID: 26877577 DOI: 10.1117/12.2081450] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Cone beam computed tomography (CBCT) systems with rotational gantries that have standard flat panel detectors (FPD) are widely used for the 3D rendering of vascular structures using Feldkamp cone beam reconstruction algorithms. One of the inherent limitations of these systems is limited resolution (<3 lp/mm). There are systems available with higher resolution but their small FOV limits them to small animal imaging only. In this work, we report on region-of-interest (ROI) CBCT with a high resolution CMOS detector (75 μm pixels, 600 μm HR-CsI) mounted with motorized detector changer on a commercial FPD-based C-arm angiography gantry (194 μm pixels, 600 μm HL-CsI). A cylindrical CT phantom and neuro stents were imaged with both detectors. For each detector a total of 209 images were acquired in a rotational protocol. The technique parameters chosen for the FPD by the imaging system were used for the CMOS detector. The anti-scatter grid was removed and the incident scatter was kept the same for both detectors with identical collimator settings. The FPD images were reconstructed for the 10 cm x10 cm FOV and the CMOS images were reconstructed for a 3.84 cm × 3.84 cm FOV. Although the reconstructed images from the CMOS detector demonstrated comparable contrast to the FPD images, the reconstructed 3D images of the neuro stent clearly showed that the CMOS detector improved delineation of smaller objects such as the stent struts (~70 μm) compared to the FPD. Further development and the potential for substantial clinical impact are suggested.
Collapse
Affiliation(s)
- A Jain
- Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY
| | - H Takemoto
- Toshiba Medical Research Institute, USA, Vernon Hills, IL
| | - M D Silver
- Consultant, Toshiba Medical Research Institute, USA, Vernon Hills, IL
| | - S V S Nagesh
- Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY
| | - C N Ionita
- Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY
| | - D R Bednarek
- Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY
| | - S Rudin
- Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY
| |
Collapse
|
22
|
Mizushima T, Ide Y, Murata K, Ohashi I, Yasumasa K, Fukunaga M, Takemoto H, Tamagawa H, Kato T, Ikenaga M, Hasegawa J, Hata T, Takemasa I, Ikeda M, Satoh T, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Phase Ii Study of Combined Chemotherapy with 5-Week Cycles of S-1 and Cpt-11 (Iris) Plus Bevacizumab in Patients with Metastatic Colon Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu333.29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
23
|
Urata Y, Furukawa KI, Takemoto H. THU0303 Influential Factor of Hepatitis B Virus Reactivation in Collagen Disease. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
24
|
|
25
|
Takemoto H, Murata K, Tomita N, Fukunaga M, Watanabe M, Ohue M, Ikeda R, Tanimoto K, Hiyama K, Nishiyama M. Pharmacogenomic analysis for prediction of individual response to mFOLFOX6 in colorectal cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e13500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
26
|
Ishida H, Miyake Y, Fukunaga M, Watanabe Y, Kato T, Takemoto H, Furukawa H. A Feasibility Study of UFT/LV and Irinotecan (TEGAFIRI) in Advanced or Metastatic Colorectal Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) PROG 0304. Jpn J Clin Oncol 2009; 39:601-5. [DOI: 10.1093/jjco/hyp067] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
27
|
Takemoto H, Tomita N, Murata K, Fukunaga M, Okamura S, Ohue M, Ishida H, Tanimoto K, Hiyama K, Nishiyama M. Optimal patient selection for CPT-11 chemotherapy in colorectal cancer: Quantitative prediction of tumor response and overall survival using expression data of novel marker genes. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e14529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e14529 Background: Unlike the toxicity, none of the critical prediction markers of CPT-11 efficacy has been validated to date. With a hypothesis that expression analysis of a set of the key drug sensitivity genes could allow us to predict the therapeutic response, we identified potent marker genes for CPT-11 in in vitro, conducted this prospective study attempting to develop a prediction formula of efficacy using the expression data (2006 ASCO, 2006 ESMO), and demonstrated the latest prediction formula of the best tumor response (BTR), time to treatment failure (TTP), and the overall survival after CPT-11 chemotherapy (OS). Methods: Seven genes identified as possible marker genes for CPT-11 (SN-38)- AMD1, CTSC, EIF1AX, FLJ13089 , DDX54, PTPN2, and TBX3-, and 5 other possible marker genes (ABCG2, CYP3A4, MGMT, POR, and TOP2A) that had already been known as drug sensitivity determinants and selected by our in vitro screening process, were studied. CPT-11 was intravenously administered on Days 1, 8, and 15, every 4 weeks in chemo-naive patients with stage IV colorectal cancer after palliative operation. Tumor samples were collected at surgery and tumor response was evaluated by RECIST. Results: All of the 44 enrolled patients were assessable for BTR (% of initial tumor size), TTP (day), and OS (day) in the clinical study, and we successfully developed the best linear model for each, which converted the quantified expression data of the 7 selected genes into objective BTR, TTP, and OS. We used 20, 16, and 15 tumor specimens and constructed potent prediction formulae for BTR (r=0.9420), TTP (r=0.7103), and OS (r=0.8406), respectively. Utility-confirmation analyses using another 16, 10, 13 clinical samples appeared to show that the formulae could predict BTR (r=0.6491, p=0.007) and OS (r=0.7947, p=0.011). We also fixed the best linear models using 5 other known marker genes, but they had less advantage in prediction. Conclusions: Despite limited data, our developed formulae using the 7 novel genes would provide advantages in prediction of individual response to CPT-11. Based on the positive results of this study, we have initiated a large scale validation study of the formula. [Table: see text]
Collapse
Affiliation(s)
- H. Takemoto
- Sakai Municipal Hospital, Sakai, Osaka, Japan; Hyogo Medical University, Nishinomiya, Hyogo, Japan; Suita Municipal Hospital, Suita, Osaka, Japan; Kansairosai Hospital, Amagasaki, Hyogo, Japan; Osaka Medical Center Cancer & Cardiovascular Diseases, Osaka, Japan; Osaka Seamen's Insurance Hospital, Osaka, Japan; Hiroshima University, RIRBM, Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - N. Tomita
- Sakai Municipal Hospital, Sakai, Osaka, Japan; Hyogo Medical University, Nishinomiya, Hyogo, Japan; Suita Municipal Hospital, Suita, Osaka, Japan; Kansairosai Hospital, Amagasaki, Hyogo, Japan; Osaka Medical Center Cancer & Cardiovascular Diseases, Osaka, Japan; Osaka Seamen's Insurance Hospital, Osaka, Japan; Hiroshima University, RIRBM, Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - K. Murata
- Sakai Municipal Hospital, Sakai, Osaka, Japan; Hyogo Medical University, Nishinomiya, Hyogo, Japan; Suita Municipal Hospital, Suita, Osaka, Japan; Kansairosai Hospital, Amagasaki, Hyogo, Japan; Osaka Medical Center Cancer & Cardiovascular Diseases, Osaka, Japan; Osaka Seamen's Insurance Hospital, Osaka, Japan; Hiroshima University, RIRBM, Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - M. Fukunaga
- Sakai Municipal Hospital, Sakai, Osaka, Japan; Hyogo Medical University, Nishinomiya, Hyogo, Japan; Suita Municipal Hospital, Suita, Osaka, Japan; Kansairosai Hospital, Amagasaki, Hyogo, Japan; Osaka Medical Center Cancer & Cardiovascular Diseases, Osaka, Japan; Osaka Seamen's Insurance Hospital, Osaka, Japan; Hiroshima University, RIRBM, Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - S. Okamura
- Sakai Municipal Hospital, Sakai, Osaka, Japan; Hyogo Medical University, Nishinomiya, Hyogo, Japan; Suita Municipal Hospital, Suita, Osaka, Japan; Kansairosai Hospital, Amagasaki, Hyogo, Japan; Osaka Medical Center Cancer & Cardiovascular Diseases, Osaka, Japan; Osaka Seamen's Insurance Hospital, Osaka, Japan; Hiroshima University, RIRBM, Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - M. Ohue
- Sakai Municipal Hospital, Sakai, Osaka, Japan; Hyogo Medical University, Nishinomiya, Hyogo, Japan; Suita Municipal Hospital, Suita, Osaka, Japan; Kansairosai Hospital, Amagasaki, Hyogo, Japan; Osaka Medical Center Cancer & Cardiovascular Diseases, Osaka, Japan; Osaka Seamen's Insurance Hospital, Osaka, Japan; Hiroshima University, RIRBM, Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - H. Ishida
- Sakai Municipal Hospital, Sakai, Osaka, Japan; Hyogo Medical University, Nishinomiya, Hyogo, Japan; Suita Municipal Hospital, Suita, Osaka, Japan; Kansairosai Hospital, Amagasaki, Hyogo, Japan; Osaka Medical Center Cancer & Cardiovascular Diseases, Osaka, Japan; Osaka Seamen's Insurance Hospital, Osaka, Japan; Hiroshima University, RIRBM, Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - K. Tanimoto
- Sakai Municipal Hospital, Sakai, Osaka, Japan; Hyogo Medical University, Nishinomiya, Hyogo, Japan; Suita Municipal Hospital, Suita, Osaka, Japan; Kansairosai Hospital, Amagasaki, Hyogo, Japan; Osaka Medical Center Cancer & Cardiovascular Diseases, Osaka, Japan; Osaka Seamen's Insurance Hospital, Osaka, Japan; Hiroshima University, RIRBM, Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - K. Hiyama
- Sakai Municipal Hospital, Sakai, Osaka, Japan; Hyogo Medical University, Nishinomiya, Hyogo, Japan; Suita Municipal Hospital, Suita, Osaka, Japan; Kansairosai Hospital, Amagasaki, Hyogo, Japan; Osaka Medical Center Cancer & Cardiovascular Diseases, Osaka, Japan; Osaka Seamen's Insurance Hospital, Osaka, Japan; Hiroshima University, RIRBM, Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - M. Nishiyama
- Sakai Municipal Hospital, Sakai, Osaka, Japan; Hyogo Medical University, Nishinomiya, Hyogo, Japan; Suita Municipal Hospital, Suita, Osaka, Japan; Kansairosai Hospital, Amagasaki, Hyogo, Japan; Osaka Medical Center Cancer & Cardiovascular Diseases, Osaka, Japan; Osaka Seamen's Insurance Hospital, Osaka, Japan; Hiroshima University, RIRBM, Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| |
Collapse
|
28
|
Liang F, Nakasone T, Arasaki A, Matayoshi A, Takemoto H, Sunakawa H. Survival analysis of 148 patients with stage I and II oral tongue squamous cell carcinoma. Int J Oral Maxillofac Surg 2009. [DOI: 10.1016/j.ijom.2009.03.510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
29
|
Kiyonaka S, Kato K, Nishida M, Mio K, Numaga T, Sawaguchi Y, Yoshida T, Wakamori M, Mori E, Numata T, Ishii M, Takemoto H, Ojida A, Watanabe K, Uemura A, Kurose H, Morii T, Kobayashi T, Sato Y, Sato C, Hamachi I, Mori Y. Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound. Proc Natl Acad Sci U S A 2009; 106:5400-5. [PMID: 19289841 PMCID: PMC2664023 DOI: 10.1073/pnas.0808793106] [Citation(s) in RCA: 283] [Impact Index Per Article: 18.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2008] [Indexed: 12/31/2022] Open
Abstract
Canonical transient receptor potential (TRPC) channels control influxes of Ca(2+) and other cations that induce diverse cellular processes upon stimulation of plasma membrane receptors coupled to phospholipase C (PLC). Invention of subtype-specific inhibitors for TRPCs is crucial for distinction of respective TRPC channels that play particular physiological roles in native systems. Here, we identify a pyrazole compound (Pyr3), which selectively inhibits TRPC3 channels. Structure-function relationship studies of pyrazole compounds showed that the trichloroacrylic amide group is important for the TRPC3 selectivity of Pyr3. Electrophysiological and photoaffinity labeling experiments reveal a direct action of Pyr3 on the TRPC3 protein. In DT40 B lymphocytes, Pyr3 potently eliminated the Ca(2+) influx-dependent PLC translocation to the plasma membrane and late oscillatory phase of B cell receptor-induced Ca(2+) response. Moreover, Pyr3 attenuated activation of nuclear factor of activated T cells, a Ca(2+)-dependent transcription factor, and hypertrophic growth in rat neonatal cardiomyocytes, and in vivo pressure overload-induced cardiac hypertrophy in mice. These findings on important roles of native TRPC3 channels are strikingly consistent with previous genetic studies. Thus, the TRPC3-selective inhibitor Pyr3 is a powerful tool to study in vivo function of TRPC3, suggesting a pharmaceutical potential of Pyr3 in treatments of TRPC3-related diseases such as cardiac hypertrophy.
Collapse
Affiliation(s)
| | | | - Motohiro Nishida
- Department of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashiku, Fukuoka 812-8582, Japan
| | - Kazuhiro Mio
- Neuroscience Research Institute, National Institute of Advanced Industrial Science and Technology, Umezono 1-1-4, Tsukuba Ibaraki 305-8568, Japan
| | | | | | | | | | | | | | - Masakazu Ishii
- Department of Pathophysiology, School of Pharmaceutical Sciences, Showa University, Tokyo 142-8555, Japan
| | - Hiroki Takemoto
- Laboratory of Bioorganic Chemistry, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan
| | - Akio Ojida
- Laboratory of Bioorganic Chemistry, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan
| | - Kenta Watanabe
- Department of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashiku, Fukuoka 812-8582, Japan
| | - Aya Uemura
- Department of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashiku, Fukuoka 812-8582, Japan
| | - Hitoshi Kurose
- Department of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashiku, Fukuoka 812-8582, Japan
| | - Takashi Morii
- Institute of Advanced Energy, Kyoto University, Uji, Kyoto 611-0011, Japan
| | - Tsutomu Kobayashi
- Pharmacology Laboratory, Mitsubishi Tanabe Pharma Corporation 2-2-50, Kawagishi, Toda 335-8505, Japan; and
| | - Yoji Sato
- National Institute of Health Sciences, Setagaya, Tokyo 158-8501, Japan
| | - Chikara Sato
- Neuroscience Research Institute, National Institute of Advanced Industrial Science and Technology, Umezono 1-1-4, Tsukuba Ibaraki 305-8568, Japan
| | - Itaru Hamachi
- Laboratory of Bioorganic Chemistry, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan
| | | |
Collapse
|
30
|
Nogami W, Yoshida H, Koizumi K, Yamada H, Abe K, Arimura A, Yamane N, Takahashi K, Yamane A, Oda A, Tanaka Y, Takemoto H, Ohnishi Y, Ikeda Y, Miyakawa Y. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis. Haematologica 2008; 93:1495-504. [DOI: 10.3324/haematol.12752] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
31
|
Miyake Y, Ishida H, Fukunaga M, Kato T, Watanabe Y, Takemoto H, Furukawa H. A feasibility/phase II study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer (CRC) (OGSG 0304). J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.15086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
32
|
Nakasone T, Sunakawa H, Makishi S, Matayoshi A, Takemoto H. Clinico-pathological and immunohistochemical studies in squamous cell carcinoma of tongue. Int J Oral Maxillofac Surg 2007. [DOI: 10.1016/j.ijom.2007.09.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
33
|
Nakamura-Kikuoka S, Takahi K, Tsuboi H, Toyosaki-Maeda T, Maeda-Tanimura M, Wakasa C, Kikuchi N, Norioka S, Iwasaki M, Matsutani T, Itoh T, Yamane S, Takemoto H, Tsuruta Y, Shimaoka Y, Yukioka M, Suzuki R, Ochi T. Limited VH gene usage in B-cell clones established with nurse-like cells from patients with rheumatoid arthritis. Rheumatology (Oxford) 2005; 45:549-57. [PMID: 16368734 DOI: 10.1093/rheumatology/kei170] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVES Nurse-like stromal cells (NLC) in synovia and bone marrow of patients with rheumatoid arthritis (RA) can support pseudoemperipolesis, protect from apoptosis and enhance immunoglobulin production of peripheral blood B cells isolated from healthy individuals, suggesting the profound contribution of hyperactivation of B cells in RA. In the course of establishing RA-NLC from RA patients, we observed the growth of B cells in the presence of RA-NLC. METHODS We cloned B cells from the synovium or bone marrow of RA patients using the limiting dilution technique. For established clones, nucleotide sequences of immunoglobulin and surface antigens were investigated. To investigate the dependence of these clones on NLC, differences in the proliferation and the amount of immunoglobulin produced in the presence or absence of NLC were compared. Immunocytochemical staining of various cells was performed using the antibody these clones produced. RESULTS Nine B-cell clones established from RA patients showed RA-NLC-dependent growth. These B-cell clones expressed CD19, CD20, CD38, CD39 and CD40, suggesting that the cloned cells were mature and activated. All clones secreted immunoglobulins in culture media, which were specific for intracellular components of various cell lines, including RA-NLC. Interestingly, we found limited usage of immunoglobulin heavy-chain variable regions (VH) among B-cell clones from RA patients. These repertoires were reported to be detected preferentially in fetal livers. CONCLUSION The present study provides a novel insight into the involvement of RA-NLC in the immunopathogenesis of RA via an autoreactive B cell development and/or activation mechanism.
Collapse
|
34
|
Kato M, Dote K, Sasaki S, Goto K, Takemoto H, Habara S, Hasegawa D. Myocardial performance index for assessment of left ventricular outcome in successfully recanalised anterior myocardial infarction. Heart 2005; 91:583-8. [PMID: 15831638 PMCID: PMC1768910 DOI: 10.1136/hrt.2004.035758] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
OBJECTIVE To investigate whether the myocardial performance index (MPI) can predict left ventricular functional outcome in patients with early recanalisation after anterior acute myocardial infarction (MI) and to determine when the index should be measured. DESIGN MPI was measured serially by two dimensional Doppler echocardiography after successful percutaneous coronary intervention (PCI). Left ventricular function was evaluated by echocardiography and left ventriculography. To assess coronary microvascular damage, the coronary flow velocity pattern was measured immediately after PCI with a Doppler guidewire. SETTING Hiroshima City Asa Hospital. PATIENTS 32 consecutive patients with their first anterior acute MI who had complete occlusion of left anterior descending coronary artery. INTERVENTIONS Successful PCI within six hours of symptom onset. MAIN OUTCOME MEASURES Left ventricular anterior wall motion score index (A-WMSI), left ventricular end diastolic pressure (LVEDP), left ventricular ejection fraction (LVEF), and left ventricular end diastolic volume (LVEDV). RESULTS There was a significant negative correlation between MPI on day 2 and the coronary diastolic deceleration time (r = -0.66, p < 0.002), as well as a significant positive correlation with the coronary diastolic deceleration rate (r = 0.74, p < 0.0001). MPI on day 2 was significantly correlated with the short and long term changes of A-WMSI and with the short term changes of LVEDP. Furthermore, MPI on day 2 was significantly correlated with the short and long term changes of LVEF (r = -0.52, p < 0.003, and r = -0.64, p < 0.0008, respectively) and of LVEDV (r = 0.51, p < 0.003, and r = 0.41, p < 0.05, respectively). CONCLUSIONS Doppler derived MPI on day 2, representative of the early coronary microvascular state, can predict the left ventricular functional outcome after early successful recanalisation of a patient's first anterior acute MI.
Collapse
Affiliation(s)
- M Kato
- Department of Cardiology, Hiroshima City Asa Hospital, 2-1-1 Kabeminami, Asakita-ku, Hiroshima 731-0293, Japan.
| | | | | | | | | | | | | |
Collapse
|
35
|
Imamura H, Furukawa H, Kishi K, Tatsuta M, Masutani S, Fukunaga M, Nakayama T, Shimizu J, Takemoto H, Kishimoto T. Which is more recommendable as the second line chemotherapy to S-1 for advanced gastric cancer; combination of CPT-11 plus CDDP or weekly paclitaxel? J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.4136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- H. Imamura
- Sakai City Hospital, Sakai, Osaka, Japan
| | | | - K. Kishi
- Sakai City Hospital, Sakai, Osaka, Japan
| | - M. Tatsuta
- Sakai City Hospital, Sakai, Osaka, Japan
| | | | | | | | - J. Shimizu
- Sakai City Hospital, Sakai, Osaka, Japan
| | | | | |
Collapse
|
36
|
Oi K, Makino M, Ozaki M, Takemoto H, Yamane N, Nakamura S, Ikeguchi M, Kaibara N. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer. Anticancer Res 2004; 24:273-9. [PMID: 15015608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
Abstract
BACKGROUND Dihydropyrimidine dehydrogenase (DPD) is an enzyme that catabolizes 5-fluorouracil (5-FU), which is widely used for chemotherapy in patients with advanced colorectal cancer (CRC). However, the clinical importance of tumor dihydropyrimidine dehydrogenase (DPD) expression in patients with CRC treated with 5-FU remains unclear. MATERIALS AND METHODS We investigated DPD activities in normal mucosa (N) and tumors (T) by enzyme-linked immunosorbent assay (ELISA) in 64 surgically resected patients with Dukes' C CRC who were treated orally with postoperative adjuvant FU-based chemotherapy. We also immunohistochemically investigated DPD expression in these specimens. The clinicopathological importance of DPD activity and expression was evaluated in the patients. RESULTS Positive DPD expression was detected in 28 tumors (43.8%) and tumor DPD activity significantly correlated with tumor DPD immunoreactivity (p=0.0121). Further, tumor DPD activity and immunoreactivity also correlated with lymph node metastatic status (p=0.0409). The disease-free survival rate of patients with positive-tumor DPD expression was significantly worse than that of patients with negative-tumor DPD expression (39.3% vs. 72.2%, p=0.0127). However, DPD activity in tumors or normal mucosa did not correlate with patient prognosis. Tumor DPD expression appeared to be an important poor prognostic factor in patients with Dukes' C CRC by multivariate analysis (p=0.013). CONCLUSION Immunohistochemical DPD expression in tumors is a useful prognostic parameter in patients with Dukes' C CRC treated with postoperative adjuvant FU-based chemotherapy.
Collapse
Affiliation(s)
- Kentaro Oi
- Department of Surgery, Division of Surgical Oncology, School of Medicine, Tottori University, 36-1 Nishi-cho, Yonago 683-8504, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
37
|
Takemoto H, Ohyama T, Tohsaki A. Direct Sum of Coulomb Potential without Ambiguities of Conditionally Convergent Series. ACTA ACUST UNITED AC 2003. [DOI: 10.1143/ptp.109.563] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
38
|
|
39
|
Préaudat M, Ouled-Diaf J, Alpha-Bazin B, Mathis G, Mitsugi T, Aono Y, Takahashi K, Takemoto H. A homogeneous caspase-3 activity assay using HTRF technology. J Biomol Screen 2002; 7:267-74. [PMID: 12097189 DOI: 10.1177/108705710200700310] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Caspases are cysteine proteases presenting a conserved active site that cleaves protein substrates at a highly specific position. They are involved in different aspects of the active cell death pathway. Most of them act through proteolytic degradations of cellular components. This paper describes the assay development, assay validation, and screening for inhibitors of this enzyme, which could be potential drug candidates. The assay uses homogeneous time-resolved fluorescence based on energy transfer from europium cryptate as donor to cross-linked allophycocyanin as acceptor (XL665). A double-tagged substrate, biotinyl-epsilon-aminocaproyl-L-aspartyl-L-glutamyl-L-valyl-Laspartyl-L-alanyl-L-propyl-N(epsilon)-(2,4-dinitrophenyl)-L-lysine-amide (biotin-X-DEVDAPK(dnp)-NH(2)), is conjugated with streptavidin cryptate and anti-dnp-XL665 monoclonal antibody. The close proximity between donor and acceptor induces a specific time-resolved fluorescence signal. In the presence of enzyme activity, the substrate cleavage induces an unlinking of the two fluorescent probes and, subsequently, the disappearance of the specific signal as a result of loss of proximity. Experiments to optimize the reagent concentration, incubation times, precision, reproducibility, and robustness are discussed in comparison with a fluorometric method.
Collapse
Affiliation(s)
- M Préaudat
- CIS Biointernational, Research and New Technologies, Bagnols-sur-Cèze, France.
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Utsunomiya T, Doki Y, Takemoto H, Shiozaki H, Yano M, Sekimoto M, Tamura S, Yasuda T, Fujiwara Y, Monden M. Correlation of beta-catenin and cyclin D1 expression in colon cancers. Oncology 2002; 61:226-33. [PMID: 11574779 DOI: 10.1159/000055379] [Citation(s) in RCA: 59] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVE Beta-catenin activates transcription by TCF/LEF and has been regarded as an oncogene in a wide range of malignant tumors. Among various molecules regulated by beta-catenin/Tcf, cyclin D1 is the most likely candidate for stimulation of the oncogenic pathway. The association between beta-catenin and cyclin D1 was investigated using clinical samples from colorectal cancers. METHODS The expression of beta-catenin and cyclin D1 was investigated by immunohistochemical analyses of samples from 70 patients with colorectal cancers. In 28 of the fresh tumor samples, beta-catenin protein was separated into soluble and insoluble fractions and quantitatively correlated with cyclin D1 protein by Western blot analysis. RESULTS Compared with noncancerous epithelium, beta-catenin and cyclin D1 were overexpressed (+) in 35 (50%) and 30 cases (43%), respectively. Cyclin D1 (+) was observed in 74% (26/35) of beta-catenin (+) cases, but only in 11% (4/35) of the beta-catenin (-) cases. Thus, there was a strong association between the expression of beta-catenin and that of cyclin D1 (p < 0.001). In the Western blot analysis, the amount of cyclin D1 correlated well with beta-catenin expression in the soluble fraction (p = 0.0016), but not with beta-catenin in the insoluble fraction or with E-cadherin expression. Beta-catenin (-)/cyclin D1 (-) cases displayed less tumor invasion than the remaining cases. However, there were no significant differences in lymph node metastasis or other clinicopathological findings. CONCLUSION Our results indicate that beta-catenin overexpression in the cytoplasm may promote malignant transformation by triggering cyclin D1 expression in colorectal cancers.
Collapse
Affiliation(s)
- T Utsunomiya
- Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Yamamoto C, Takemoto H, Kuno K, Yamamoto D, Nakai K, Baden T, Kamata K, Hirata H, Watanabe T, Inoue K. Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human colon cancer cell lines in vitro. Oncol Rep 2001; 8:821-4. [PMID: 11410791 DOI: 10.3892/or.8.4.821] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Recently, we reported that cycloprodigiosin hydrochloride (cPrG.HCl), a novel H+/Cl- symporter, induces acidification of the cytosol and leads to apoptosis on rat and human liver cancer cells. In the present study, the effects of cPrG.HCl, a H+/Cl- symporter, were examined in colon cancer cell lines in vitro. In the MTT assay, cPrG.HCl inhibited the growth of two colon cancer cell lines (WiDr and SW480) in a dose- and time-dependent manner. The cPrG.HCl treatment of both types of cells induced apoptosis as confirmed by the appearance of a sub-G1 population and intranucleosomal DNA fragmentation. In addition, cPrG.HCl lowered pHi (below pH 6.8) respectively. Therefore, these results suggest that cPrG.HCl may be useful for the treatment of colon cancer cells.
Collapse
Affiliation(s)
- C Yamamoto
- Department of Internal Medicine III, Kansai Medical University, Moriguchi, Osaka 570-8506, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Miyata H, Doki Y, Yamamoto H, Kishi K, Takemoto H, Fujiwara Y, Yasuda T, Yano M, Inoue M, Shiozaki H, Weinstein IB, Monden M. Overexpression of CDC25B overrides radiation-induced G2-M arrest and results in increased apoptosis in esophageal cancer cells. Cancer Res 2001; 61:3188-93. [PMID: 11306507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
CDC25B phosphatase plays a key role in controlling G2-M progression by dephosphorylating two inhibitory residues of CDC2 and also has been suggested to have an oncogenic property. In this study, we investigated the effect of CDC25B overexpression on radiation-induced G2-M arrest and radiation sensitivity in esophageal cancer cells. TE8-CDC25B, in which CDC25B was overexpressed under an inducible system, was more radiosensitive than the vector control (TE8-neo) in a clonogenic survival assay. Without radiation, CDC25B overexpression had little effect on cell cycle fractions or growth rate. After 10-Gy radiation, TE8-CDC25B showed decreased G2-M arrest and increased apoptosis, whereas TE8-neo displayed prolonged G2-M arrest and less apoptosis. During this period, there were no differences in the protein amounts of CDC2 and cyclin B1 between the two cell lines. However, more CDC25B expression, which was reduced immediately by radiation, was sustained in TE8-CDC25B than in TE8-neo. Moreover, induction of tyrosine phosphorylation of CDC2 and reduction of CDC2 kinase activity after irradiation was less significant in TE8-CDC25B than in TE8-neo. These results indicate that cancer cells that overexpress CDC25B override G2-M arrest by retaining CDC2 kinase activity and undergo apoptosis after radiation. This may point to an effective approach toward improving radiotherapy outcomes of various cancers.
Collapse
Affiliation(s)
- H Miyata
- Department, of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Japan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Takemoto H, Doki Y, Shiozaki H, Imamura H, Utsunomiya T, Miyata H, Yano M, Inoue M, Fujiwara Y, Monden M. Localization of IQGAP1 is inversely correlated with intercellular adhesion mediated by e-cadherin in gastric cancers. Int J Cancer 2001; 91:783-8. [PMID: 11275980 DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1121>3.0.co;2-z] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Down-regulation of E-cadherin function is characteristic of cancer cells and might involve the small G-protein Rho family, including Rac1 and Cdc42. IQGAP1 has been reported to be one of the target proteins of Rac1 and Cdc42. To elucidate the role of IQGAP1 in cancer-cell adhesion, its expression was investigated in 47 cases of human gastric cancer by immunohistochemistry and Western blot upon protein fractionation, especially in comparison with E-cadherin and catenin expression. In the non-cancerous columnar epithelium of the stomach, IQGAP1, as well as E-cadherin/catenin, was expressed at the cell-cell boundary. IQGAP1 was frequently observed diffusely in the cytoplasm in intestinal-type tumors (20/22 cases) but was expressed at the cell membrane in diffuse-type tumors (19/25 cases), thus showing significant association with tumor differentiation (p < 0.01). Interestingly, membranous expression of IQGAP1 was inversely correlated with that of E-cadherin (p < 0.05) or alpha-catenin (p < 0.001). These observations were consistent with the Western blot results following protein fractionation. IQGAP1 was dominantly expressed in the soluble fraction in differentiated tumors; however, in undifferentiated tumors, it was mostly in the insoluble fraction. In contrast, both E-cadherin and alpha-catenin were detected only in the insoluble fraction. Thus, subcellular localization of IQGAP1 from the cytoplasm to the cell membrane was correlated with E-cadherin dysfunction and tumor dedifferentiation in gastric carcinogenesis.
Collapse
Affiliation(s)
- H Takemoto
- Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, 2-2-E2, Yamadaoka, Suita, Osaka 565-0871 Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Abstract
Skilled movements of the tongue in speech articulation reflect complex formation of the tongue musculature, although its description in the anatomical literature is rather limited for developing a realistic computational model of the tongue. This study presents detailed descriptions of the muscular structure of the human tongue based on macroscopic and microscopic observations and provides three-dimensional schemata of the tongue musculature. Histologic examination revealed that the tongue consists of five strata, stacked along the courses of the fibers of the genioglossus muscle in proximal-distal directions. This stratum structure exists in the entire tongue tissue, indicating that the lingual musculature can be divided into the inner and outer regions. The former consisted of the "stem" and "core," and the latter of the "cover" and "fringe." In gross dissection, the tongue was cut into wedge-like blocks along the course of the genioglossus muscle to examine muscle fiber arrangement. Using this approach, it was determined that serial repetitions of "structural units" composed the inner musculature of the tongue. Each unit consisted of a pair of thin muscle fiber laminae; one was composed of the genioglossus and vertical muscles, and the other of the transverse muscle. In the apex, the laminae lacked the fibers of the genioglossus. These findings have been incorporated in three-dimensional schemata of the tongue musculature.
Collapse
Affiliation(s)
- H Takemoto
- Laboratory of Physical Anthropology, Graduate School of Science, Kyoto University, Japan.
| |
Collapse
|
45
|
Yamamoto D, Uemura Y, Tanaka K, Nakai K, Yamamoto C, Takemoto H, Kamata K, Hirata H, Hioki K. Cycloprodigiosin hydrochloride, H(+)/CL(-) symporter, induces apoptosis and differentiation in HL-60 cells. Int J Cancer 2000; 88:121-8. [PMID: 10962449 DOI: 10.1002/1097-0215(20001001)88:1<121::aid-ijc19>3.0.co;2-c] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Cycloprodigiosin hydrochloride (cPrG * HCl), a novel H(+)/Cl(-) symporter, induces acidification of the cytosol and leads to apoptosis in rat and human liver cancer cells. In the present study, the effect of cPrG * HCl on a promyelocytic leukemia cell line (HL-60) was examined. cPrG * HCl lowered intracellular pH and induced apoptosis through up-regulation of Fas ligand, activation of stress-activated protein kinase (SAPK/JNK) and caspase. Apoptosis induced by cPrG * HCl was strongly suppressed when a cell-permeable weak base, imidazole, was present, indicating that cytosol acidification introduced by cPrG * HCl triggered caspase activation, leading to apoptosis. Concomitantly, cell differentiation into monocyte was also induced by cPrG * HCl both morphologically and functionally. However, the cPrG * HCl-induced differentiation was not suppressed by addition of imidazole, indicating that the differentiation process is unrelated to cytosol acidification. Further, the differentiation induced by cPrG * HCl was blocked by tyrosine kinase inhibitors (lavendustin A and HMA) but unaffected by the inhibitors of A-kinase (H-89) or C-kinase (H-7). Taken together, these findings suggest that cPrG * HCl, through apoptosis and differentiation induction, may be useful in leukemia treatment.
Collapse
Affiliation(s)
- D Yamamoto
- Department of Surgery II, Kansai Medical University, Moriguchi, Osaka, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Enomoto K, Aono Y, Mitsugi T, Takahashi K, Suzuki R, Préaudat M, Mathis G, Kominami G, Takemoto H. High throughput screening for human interferon-gamma production inhibitor using homogenous time-resolved fluorescence. J Biomol Screen 2000; 5:263-8. [PMID: 10992047 DOI: 10.1177/108705710000500409] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
An immunoassay for interferon-gamma (IFN-gamma) using homogeneous time-resolved fluorescence (HTRF) has been developed. In this assay, IFN-gamma can be detected by simply adding a mixture of three reagents-biotinylated polyclonal antibody, europium cryptate (fluorescence donor, EuK)-labeled monoclonal antibody, and crosslinked allophycocyanin (fluorescence acceptor, XL665) conjugated with streptavidin-and then measuring the time-resolved fluorescence. The detection limit of IFN-gamma by the proposed method is about 625 pg/ml. We applied the method to the detection of IFN-gamma secreted from NK3.3 cells and employed it in high throughput screening for IFN-gamma production inhibitors. With this screening format, IFN-gamma can be measured by directly adding the above reagents to microplate wells where NK3.3 cells are being cultured and stimulated with interleukin-12. This "in situ" immunoassay requires only pipetting reagents, with no need to transfer the culture supernatant to another microplate or wash the plate. Therefore, this screening format makes possible full automation of cell-based immunoassay, thus reducing cost and experimental time while increasing accuracy and throughput.
Collapse
Affiliation(s)
- K Enomoto
- Chemical Analysis Laboratories, Shionogi & Co, Ltd, Osaka, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Yamamoto D, Kiyozuka Y, Uemura Y, Yamamoto C, Takemoto H, Hirata H, Tanaka K, Hioki K, Tsubura A. Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human breast cancer cell lines. J Cancer Res Clin Oncol 2000; 126:191-7. [PMID: 10782891 DOI: 10.1007/s004320050032] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
The effect of cycloprodigiosin hydrochloride (cPrG.HCl), a H+/Cl- symporter, on five human breast cancer cell lines (KPL-1, T-47D, MCF-7, MKL-F, and MDA-MB-231), a human breast epithelial cell line (HBL-100), and a human fibroblast cell line (WI-38-40) was examined. cPrG.HCl inhibited the growth of all five breast cancer cell lines (IC50: 0.46-0.62 microM) and slightly inhibited HBL-100 and WI-38-40 cell growth (IC50: 1.75 microM and 2.26 microM respectively). cPrG.HCl treatment in KPL-1 cells increased the pH of acidic organelles, decreased intracellular pH, and caused apoptosis, which was confirmed by the appearance of a sub-G1 population by flow cytometry and DNA fragmentation. In addition, cPrG.HCl-induced apoptosis was strongly suppressed by imidazole, a cell-permeable base, suggesting that intracellular acidification was essential for the apoptosis. Further, cPrG.HCl treatment up-regulated Bax and Bak expression, down-regulated Bcl-2 expression, and activated caspase-3. Therefore, the intracellular acidification by cPrG.HCl treatment suppressed the growth of human breast cancer cell lines by inducing apoptosis.
Collapse
Affiliation(s)
- D Yamamoto
- Department of Pathology II, Kansai Medical University, Moriguchi, Osaka, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Koreeda C, Kawa SK, Takasu M, Satoh M, Takemoto H, Mizuno T, Sawada S, Inoue K. A study of colloidal scintigraphy in alcoholic liver diseases: discordance from asialo-scintigraphic findings. Alcohol Clin Exp Res 2000; 24:43S-47S. [PMID: 10803779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
BACKGROUND Our study was undertaken to check the discordance between findings from 99mTc-Sn colloidal reticuloendothelial scintigraphy (RESS) and 99mTc-GSA asialo-scintigraphy (GSA, a technique for evaluation of liver parenchymal cell density and function) and to analyze the discordance in relation to functional disturbances. We compared data between patients with alcoholic liver diseases (ALD) and patients with viral liver diseases (VLD). METHODS The subjects of this study were 40 patients with chronic liver disease (17 with ALD and 23 with VLD). We used the liver uptake ratio of the tracer of the Sn colloid (SnL15, %), the liver uptake rate (GSAL15, %), and the Rmax (an indicator of total liver receptors) as indices of liver scans. RESULTS GSAL15 was sometimes nondiscordant from SnL15. The patients were divided into two groups: the nondiscordant group (26 cases where the balance/sum of the two variables was <25%) and the discordant group (14 cases where the balance/sum was > or =25%). SnL15 was 41.6 +/- 16.2% in the nondiscordant group and 42.7 +/- 16.3% in the discordant group (p = 0.80). GSAL15 was 34.3 +/- 12.1% in the nondiscordant group and 21.5 +/- 8.1% in the discordant group (p = 0.001). Rmax was 0.33 +/- 0.17 in the nondiscordant group and 0.113 +/- 0.008 in the discordant group (p = 0.002). Thus, the SnL15, as determined by RESS, did not differ significantly between the nondiscordant and discordant groups, whereas GSAL15 was significantly unfavorable in the discordant group as compared with the nondiscordant group. SnL15 as determined by RESS did not differ significantly between the ALD group (40.4 +/- 18.7%) and the VLD group (43.5 +/- 15.0%) (p = 0.59), whereas Rmax as determined by GSA was significantly improved in the ALD group (0.34 +/- 0.20) compared with the VLD group (0.20 +/- 0.4) (p = 0.02). CONCLUSIONS Liver cell function was lower in cases that showed discordance between liver cell function and reticuloendothelial function compared with cases without such discordance, although reticuloendothelial function did not differ between discordant and nondiscordant groups. Liver cell function was better in cases of ALD than in cases of VLD, whereas reticuloendothelial function did not differ between the ALD group and the VLD group.
Collapse
Affiliation(s)
- C Koreeda
- Third Department of Internal Medicine, Kansai Medical University, Moriguchi, Osaka, Japan
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Yamamoto C, Takemoto H, Kuno K, Yamamoto D, Tsubura A, Kamata K, Hirata H, Yamamoto A, Kano H, Seki T, Inoue K. Cycloprodigiosin hydrochloride, a new H(+)/Cl(-) symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice. Hepatology 1999; 30:894-902. [PMID: 10498640 DOI: 10.1002/hep.510300417] [Citation(s) in RCA: 89] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/07/2022]
Abstract
The effects of cycloprodigiosin hydrochloride (cPrG-HCl), a new H(+)/Cl(-) symporter, were examined in liver cancer cell lines in vitro and in vivo. In the in vitro MTT assay, cPrG-HCl inhibited the growth of 6 liver cancer cell lines (Huh-7, HCC-M, HCC-T, dRLh-84, and H-35, hepatocellular carcinoma; HepG2, hepatoblastoma) in a dose- and time-dependent manner. The 50% inhibitory concentrations (IC(50)) at 72 hours' treatment for liver cancer cell lines were 276 to 592 nmol/L, while that for isolated normal rat hepatocyte was 8.4 micromol/L. The cPrG-HCl treatment of Huh-7 cells induced apoptosis as confirmed by the appearance of a subG(1) population, intranucleosomal DNA fragmentation, and chromatin condensation. cPrG-HCl raised the pH of acidic organelles and lowered pHi (below pH 6.8). In addition, the apoptosis in Huh-7 cells induced by cPrG-HCl was strongly suppressed when the cells were cultured with imidazole, a cell-permeable base. In the in vivo assay, nude mice bearing subcutaneous xenografted Huh-7 cells received 2 weeks of treatment with cPrG-HCl (1 or 10 mg/kg/d) subcutaneously. This treatment significantly inhibited tumor growth compared with the control after 8 days. The control mice were treated with 1% dimethylsulfoxide (DMSO) in saline (vehicle). A histopathological examination using the terminal deoxynucleotidyl transferase mediated dUTP biotin nick end labeling (TUNEL) method showed apoptosis in the treated tumor cells. No pathological changes were observed in any organs, and the serum alanine transaminase levels remained within normal limits. These results suggest that cPrG-HCl may be useful for the treatment of hepatocellular carcinoma.
Collapse
Affiliation(s)
- C Yamamoto
- Department of Internal Medicine III, Kansai Medical University, Moriguchi, Osaka, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Matsushita M, Matsuzaki K, Date M, Watanabe T, Shibano K, Nakagawa T, Yanagitani S, Amoh Y, Takemoto H, Ogata N, Yamamoto C, Kubota Y, Seki T, Inokuchi H, Nishizawa M, Takada H, Sawamura T, Okamura A, Inoue K. Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development. Br J Cancer 1999; 80:194-205. [PMID: 10389996 PMCID: PMC2362997 DOI: 10.1038/sj.bjc.6690339] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
Many colorectal cancer cells are resistant to the anti-proliferative effects of transforming growth factor-beta (TGF-beta). TGF-beta also acts as paracrine factor from cancer cells on their mesenchymal cells. The aim of this study was to examine the expression of TGF-beta and its receptors in human colorectal cancer tissue and determine any relationship with cancer growth. In situ hybridization and Northern blot hybridization detection of TGF-beta1, type I and type II receptor mRNA and immunohistochemical staining of TGF-beta1 were performed using 11 human colorectal adenomas, 22 colorectal cancers and ten normal colorectal mucosas as control. TGF-beta receptor mRNAs were expressed mainly by normal colorectal epithelial cells and adenoma. However, mRNAs for TGF-beta receptors were only faintly, if at all, expressed in eight of 22 human colorectal cancers. In addition, intense signals of TGF-beta1 mRNA and the protein were detected in all colorectal cancers. TGF-beta receptor mRNAs and TGF-beta1 protein were also distributed in fibroblasts and endothelial cells in the interstitium. Moreover, Smad 4 protein was translocated to nucleus in primarily cultured adenoma cells, but not in cancer cells after TGF-beta stimulation. The escape of human colon cancer from TGF-beta-mediated growth inhibition by down-regulation of TGF-beta receptors as well as the effects of TGF-beta on stroma formation and angiogenesis indicate a possible role for TGF-beta in the progression of colon cancer in an intact host.
Collapse
Affiliation(s)
- M Matsushita
- Third Department of Internal Medicine, Kansai Medical University, Moriguchi, Osaka, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|